Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03495388 · ClinicalTrials.gov registry record
PG and PK of Oxycodone to Personalize Post-op Pain Management Following Surgery in Children
A clinical trial of Postoperative Pain and Opioid Dependence, sponsored by Senthil Sadhasivam.
- Completed
- Registry status
- 129
- Enrollment target
- 2
- Study locations
NCT03495388 is a study of Postoperative Pain and Opioid Dependence that has completed, run by Senthil Sadhasivam. The registered enrollment target is 129 participants, below the 229-participant average among 63 other Postoperative Pain trials with a reported enrollment target (44% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT03495388, a study of Postoperative Pain and Opioid Dependence, has completed, sponsored by Senthil Sadhasivam.
- COMPLETED
- Registry status
- 129 participants
- Enrollment target
- 2
- Study locations
Study Summary
Each year, in the U.S. alone, \>6 million children undergo painful surgery; up to 50% of them experience significant and serious side effects with opioids and inadequate pain relief. Though 60% of this inter-individual variability in responses results from genetic variations, there is an almost complete lack of understanding of how specific genetic variability affects pain and of the adverse effects of opioids, especially in children. In this project the investigators will focus on oxycodone, a standard and preferred post-surgical oral analgesic in children The purpose of this research is to study serious immediate and long-term clinical problems from both surgical pain and oxycodone use in children and adolescents to improve the safety and effectiveness of surgical pain relief. The long-term goals are to improve the safety and effectiveness of surgical pain relief with opioids (a class of drugs/pain relievers) and to minimize the societal burden of disabling Chronic Persistent Surgical Pain (CPSP, which is pain that persists even after the expected healing time from surgery) and Opioid Dependence (OD) by preoperative risk predictions and personalized care with the right dose of the right pain medication for each child. The overall objective is to determine the impact of risk factors on oxycodone's immediate and long-term negative postoperative outcomes and to personalize dosing in children undergoing outpatient and major inpatient surgery.
Conditions Studied
Interventions
- DRUG Oxycodone
Study Locations (2)
Indiana
- Riley Hospital for Children - Indianapolis
Pennsylvania
- UPMC Children's Hospital - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 129 participants |
| Start Date | 2018-04-01 |
| Est. Completion | 2022-06-15 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03495388
The ClinicalTrials.gov registry entry for NCT03495388 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 129 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 229-participant average among 63 other Postoperative Pain trials with a reported enrollment target (44% lower). The listed sponsor is Senthil Sadhasivam, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Postoperative Pain appearing as the primary indexed condition, and to 1 intervention - of which Oxycodone is the first listed.
NCT03495388 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Indiana, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT03495388 about?
NCT03495388 is a clinical study titled "PG and PK of Oxycodone to Personalize Post-op Pain Management Following Surgery in Children". Each year, in the U.S. alone, \>6 million children undergo painful surgery; up to 50% of them experience significant and serious side effects with opioids and inadequate pain relief. Though 60% of this inter-individual variability in responses results from genetic variations, there is an almost comp...
What is the current status of trial NCT03495388?
This trial is currently completed. The enrollment target is 129 participants. The study started on 2018-04-01. Estimated completion is 2022-06-15.
What conditions does trial NCT03495388 study?
This clinical trial studies the following conditions: Postoperative Pain, Opioid Dependence.
What interventions are being tested in trial NCT03495388?
The interventions under investigation include: Oxycodone (DRUG).
Who is sponsoring clinical trial NCT03495388?
This trial is sponsored by Senthil Sadhasivam, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03495388 being conducted?
This trial has 2 study locations across Indiana, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Postoperative Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study of TLC590 for Postsurgical Pain Following Bunionectomy
RECRUITING · Phase 3
-
A Clinical Trial of Intravenous Lidocaine After Spinal Surgery to Prevent Delirium and Reduce Pain
RECRUITING · Phase 3
-
Characterization of Acute Pain
RECRUITING
-
Ketamine in Patients Undergoing TEVAR Procedures Receiving NCI
RECRUITING · Phase 2
-
Opioid Prescribing Practices in Laparoscopic Gynecologic Surgery
RECRUITING · NA
-
Virtual Reality and Olfactory Stimuli Multimodal Intervention to Reduce Post-Operative Pain and Anxiety in Patients Undergoing Cardiothoracic Surgery
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.